Article
Tuberous Sclerosis Complex Associated with Vascular Anomalies or Overgrowth.
Pediatric dermatology - 1 Sept 2016
Jenkins David, McCuaig Catherine, Drolet Beth A, Siegel Dawn, Adams Susan, Lawson John A, Wargon Orli
Abstract excerpt
BACKGROUND: Dysregulation of the mammalian target of rapamycin pathway is the underlying pathogenic mechanism in tuberous sclerosis complex (TSC). Other syndromes caused by genetic alterations in this pathway frequently manifest as vascular anomalies or asymmetric overgrowth. Rarely, these features have been documented in TSC. OBJECTIVE: To collate cases of TSC with vascular anomaly or overgrowth that have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.